about
negative regulation of phosphatidylcholine catabolic processnegative regulation of triglyceride catabolic processnegative regulation of fatty acid beta-oxidationnegative regulation of butyryl-CoA catabolic process to butanolnegative regulation of butyryl-CoA catabolic process to butyratenegative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic processnegative regulation of glucocorticoid catabolic processnegative regulation of juvenile hormone catabolic processnegative regulation of prostaglandin catabolic process
P279
Insulin IIAdenosine A1 receptorAPOC1Apolipoprotein C-IAPOC3Interleukin 1 betaApolipoprotein C1BSCL2 lipid droplet biogenesis associated, seipinFMC1-LUC7L2 readthroughProtein kinase AMP-activated catalytic subunit alpha 1Cell death inducing DFFA like effector aCREB regulated transcription coactivator 3Phosphodiesterase 3BPerilipin 5Acetyl-CoA carboxylase betaApolipoprotein A2INSHydroxycarboxylic acid receptor 2Tumor necrosis factorAcetyl-Coenzyme A carboxylase betaCREB regulated transcription coactivator 3Cell death-inducing DNA fragmentation factor, alpha subunit-like effector AProtein kinase, AMP-activated, alpha 1 catalytic subunitAlpha-2A adrenergic receptorApolipoprotein A-IIBerardinelli-Seip congenital lipodystrophy 2 (seipin)Hydroxycarboxylic acid receptor 1Hydroxycarboxylic acid receptor 2Phosphodiesterase 3B, cGMP-inhibitedPerilipin 5Tumor necrosis factorFormation of mitochondrial complex V assembly factor 1Adenosine A1 receptorFormation of mitochondrial complex V assembly factor 1Apolipoprotein A2GTPase, IMAP family member 5Perilipin 5BSCL2 lipid droplet biogenesis associated, seipinHydroxycarboxylic acid receptor 2Protein kinase AMP-activated catalytic subunit alpha 1
P682
Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesityMechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytesResistin in dairy cows: plasma concentrations during early lactation, expression and potential role in adipose tissueA human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity
P921
Q14904543-139E1337-793E-4D08-8262-36CBCD834927Q14910483-F863FA00-D4FF-40EC-B113-F7EB54873349Q21114986-D08A2025-2EB4-44D2-8CB5-0564AD30C798Q22304251-9E701DCC-883E-4050-B37D-360BC88CDD80Q22304255-456129A2-649F-4730-ABA8-11BB5F4D7FF8Q22304294-C02DD1FA-D3CC-4A9A-839D-A0B9F129C1DCQ22304406-9D23C091-8E1D-422D-995D-E830BDED98A0Q22304583-FEBA1460-0A3F-473D-A7DD-656CAC2A12F1Q28597730-1744BD96-B063-4DBF-BB11-7B455088BEBC
P279
Q14762286-B2CA857A-CA0E-48BE-9AEB-DDE5751F4B3EQ14888630-13B0A1A8-13A9-4FD1-92BE-4FB0F05F7072Q14904550-1D776F69-E322-4AC0-B048-FF9EF44A86C5Q14904553-C1E8D4D5-C58F-497C-B0A7-131F5D4DECDCQ14910515-F7D12B02-DCB7-4B89-A4FA-28B962A6012AQ14916414-661248F8-986E-4103-B5A2-B1899B37DAEDQ1977297-310C0645-C056-402A-BB58-DAFB6BC52CF6Q21100511-3A812993-4355-4E73-9EC6-5D56E81550E3Q21109762-EF548DF4-8924-4088-A20C-5B198228BA29Q21115170-AB05E3C3-6803-4871-9695-5CB04FC781E3Q21115661-0B0EFCF8-1595-4E73-91D1-DE1E955DA370Q21115716-25DE78E5-776A-4331-A039-40939EF0AD02Q21123244-60EA8A9A-7CCA-44BF-8476-BD396325D57FQ21123271-4B677384-35BF-42D1-AC78-990AE71B2703Q21132362-9F3B2A2A-B04F-413A-9CAB-6585174DFCB7Q21154572-EF7E6A9E-8816-4BAF-BC83-05989B96A3FFQ21163221-B5C0127B-56E7-41D3-A05C-7CD1882C7637Q21173485-86DDA624-4C11-49F4-8B16-DE020A5E8B7BQ21173843-1D5F06AC-0F1A-4DBD-881C-6BB090EA29BAQ21497954-11255ABD-4D00-4273-824D-5E3EEB54C422Q21498178-DF58FC94-2819-4F08-92D9-C7D3A9833A01Q21498723-6BFE0335-2421-450D-924C-B0D96F94BD80Q21498728-C693DB2F-85C5-4CD0-91FE-02842AD1915DQ21498844-A40E88CB-C3F0-434E-835A-3A71988D83E3Q21498844-B5D693F6-5C79-414F-93EC-612F0306BF90Q21499493-F1B51F08-4A5F-4A04-AE03-A929C2100A38Q21981520-A6831A8D-5511-4EFC-8B17-6E12F173C734Q21985448-9F7EE849-F5F6-49AE-9A27-2A0117AE5AA1Q21985450-D7EABD00-08D7-4C1D-8403-AA20C6554F2AQ21986242-032287B3-33DB-4098-A017-30A9AA6667B9Q21988927-B8FBF877-9892-4F32-8AA3-8C1C899E4220Q21992447-92D8A7DB-1959-48DE-8B97-5E85BFBE1B7AQ22677277-F67C7292-ABDC-4272-AFCA-4124BDFD2ABBQ28557361-3D36A547-47A4-423E-BD57-0592BB55EDDCQ28559043-98701256-ABAB-442E-AF78-E239154D5085Q28559398-3E50EFFF-9E7E-43C9-AE37-E46A4842FF68Q28559547-969503C7-2E18-4448-AF6F-5BC5D7CD904DQ28560186-BBAB434E-CC88-4C90-A656-273852D7F9E0Q28561702-B049106B-F3EA-4428-93BC-30F2C1B698FEQ28561820-0D00337A-3BFA-4FE0-BE27-1C70BAF91C33
P682
description
Any process that stops, preven ...... ng in the breakdown of lipids.
@en
biologisch proces
@nl
name
negative regulation of lipid catabolic process
@en
type
label
negative regulation of lipid catabolic process
@en
altLabel
GO:0050995
@en
down regulation of lipid catabolic process
@en
down-regulation of lipid catabolic process
@en
downregulation of lipid catabolic process
@en
negative regulation of lipid breakdown
@en
negative regulation of lipid catabolism
@en
negative regulation of lipid degradation
@en
prefLabel
negative regulation of lipid catabolic process
@en
P279
P279
P2888
P686
GO:0050995